JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ziessman, H. A.
Right arrow Articles by Agarval, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ziessman, H. A.
Right arrow Articles by Agarval, A. K.
Journal of Nuclear Medicine Vol. 44 No. 8 1263-1266
© 2003 by Society of Nuclear Medicine


Clinical Investigations

Cholecystokinin Cholescintigraphy: Methodology and Normal Values Using a Lactose-Free Fatty-Meal Food Supplement

Harvey A. Ziessman, MD, Douglas A. Jones, MD, Larry R. Muenz, PhD and Anup K. Agarval, MS

Department of Radiology, Georgetown University Hospital, Washington, DC

The purpose of this investigation was to evaluate the use of a commercially available lactose-free fatty-meal food supplement, as an alternative to sincalide cholescintigraphy, to develop a standard methodology, and to determine normal gallbladder ejection fractions (GBEFs) for this supplement. Methods: Twenty healthy volunteers all had negative medical histories for hepatobiliary and gallbladder disease, had no personal or family history of hepatobiliary disease, and were not taking any medication known to affect gallbladder emptying. All were prescreened with a complete blood cell count, comprehensive metabolic profile, gallbladder and liver ultrasonography, and conventional cholescintigraphy. Three of the 20 subjects were eliminated from the final analysis because of an abnormality in one of the above studies. Results: After gallbladder filling on conventional cholescintigraphy, the subjects ingested the supplement and an additional 60-min study was acquired. GBEFs were calculated and ranged from 33% to 95% (mean ± SD, 62.6% ± 21.3%). Statistical analysis determined the lower range of normal to be 32.6%. Maximal gallbladder emptying occurred between 55 and 60 min. Conclusion: A standard methodology and normal GBEFs (>=33%) were established for supplement-stimulated cholescintigraphy.

Key Words: cholescintigraphy • cholecystokinin • gallbladder




This article has been cited by other articles:


Home page
JNMHome page
T. B. Bartel, M. E. Juweid, J. A. Ponto, and M. M. Graham
Corn Oil Emulsion: A Simple Cholecystagogue for Diagnosis of Chronic Acalculous Cholecystitis
J. Nucl. Med., January 1, 2005; 46(1): 67 - 74.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2003 by the Society of Nuclear Medicine.